Market revenue in 2023 | USD 4,444.0 million |
Market revenue in 2030 | USD 7,955.1 million |
Growth rate | 8.7% (CAGR from 2023 to 2030) |
Largest segment | Contract manufacturing |
Fastest growing segment | Contract Development |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Contract Development, Contract Manufacturing |
Key market players worldwide | Catalent Inc, Lonza Group Ltd, Recipharm, Siegfried Holding AG, Thermo Fisher Scientific Inc, Labcorp Drug Development, Jabil Inc, Syngene, IQVIA Holdings Inc, Almac Group, Ajinomoto Co Inc, Alcami, Vetter Pharma-Fertigung |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to healthcare contract development and manufacturing organization market will help companies and investors design strategic landscapes.
Contract manufacturing was the largest segment with a revenue share of 82.23% in 2023. Horizon Databook has segmented the Spain healthcare contract development and manufacturing organization market based on contract development, contract manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
Spain is an important medical devices market in the EU due to its large population of over 47 million, as of 2019. Small and midsized companies take up nearly 90% of the market and are responsible for more than 40% of medical device sales.
Large companies account for 8% to 10% of the market space and generate approximately 60% of sales. Spain has a universal and free healthcare system. As the number of patients is increasing, the demand for medical products is growing in the country. Rise in the number of manufacturing facilities in the country is anticipated to fuel the market.
For instance, in 2020, AGC, Inc. announced expansion of its production capabilities and establishment of a new R&D facility of its pharma CDMO subsidiary located in Spain.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain healthcare contract development and manufacturing organization market , including forecasts for subscribers. This country databook contains high-level insights into Spain healthcare contract development and manufacturing organization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account